Diagnosis of multiple sclerosis: progress and challenges

WJ Brownlee, TA Hardy, F Fazekas, DH Miller - The Lancet, 2017 - thelancet.com
The diagnosis of multiple sclerosis is based on neurological symptoms and signs, alongside
evidence of dissemination of CNS lesions in space and time. MRI is often sufficient to …

Blood neurofilament light: a critical review of its application to neurologic disease

C Barro, T Chitnis, HL Weiner - Annals of clinical and …, 2020 - Wiley Online Library
Neuronal injury is a universal event that occurs in disease processes that affect both the
central and peripheral nervous systems. A blood biomarker linked to neuronal injury would …

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

AJ Thompson, BL Banwell, F Barkhof… - The Lancet …, 2018 - thelancet.com
The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in
research and clinical practice. Scientific advances in the past 7 years suggest that they might …

Association of early progression independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis

C Tur, P Carbonell-Mirabent, Á Cobo-Calvo… - JAMA …, 2023 - jamanetwork.com
Importance Progression independent of relapse activity (PIRA) is the main event responsible
for irreversible disability accumulation in relapsing multiple sclerosis (MS). Objective To …

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

CH Polman, SC Reingold, B Banwell… - Annals of …, 2011 - Wiley Online Library
New evidence and consensus has led to further revision of the McDonald Criteria for
diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of …

[HTML][HTML] The cerebrospinal fluid in multiple sclerosis

F Deisenhammer, H Zetterberg, B Fitzner… - Frontiers in …, 2019 - frontiersin.org
Investigation of cerebrospinal fluid (CSF) in the diagnostic work-up in suspected multiple
sclerosis (MS) patients has regained attention in the latest version of the diagnostic criteria …

γ-Secretase directly sheds the survival receptor BCMA from plasma cells

SA Laurent, FS Hoffmann, PH Kuhn, Q Cheng… - Nature …, 2015 - nature.com
Survival of plasma cells is regulated by B-cell maturation antigen (BCMA), a membrane-
bound receptor activated by its agonist ligands BAFF and APRIL. Here we report that γ …

Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study

J Kuhle, G Disanto, R Dobson… - Multiple Sclerosis …, 2015 - journals.sagepub.com
Background and objective: We explored which clinical and biochemical variables predict
conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis …

The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review

D Karussis - Journal of autoimmunity, 2014 - Elsevier
Multiple sclerosis (MS), is a chronic disease of the central nervous system (CNS)
characterized by loss of motor and sensory function, that results from immune-mediated …

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

CH Polman, SC Reingold, G Edan… - Annals of Neurology …, 2005 - Wiley Online Library
New diagnostic criteria for multiple sclerosis integrating magnetic resonance image
assessment with clinical and other paraclinical methods were introduced in 2001. The …